Raphael Warnock, the U.S. Senator from Georgia, and Robert F. Kennedy Jr., a prominent public health advocate and former independent presidential candidate, occupy vastly different political ecosystems in 2028. The Warnock market tests whether the Democratic Party would nominate an incumbent U.S. Senator with deep roots in swing-state politics, while the Kennedy market gauges whether the Republican Party would turn to an outsider with a controversial public health record. On the surface, these are independent questions about two parties' preferences, yet both share a common thread: both candidates represent paths away from establishment-preferred frontrunners. Warnock brings electoral credibility and existing donor networks; Kennedy brings media prominence but limited party infrastructure. Both markets are trading at an identical 1% YES price, a critical signal that traders perceive each candidate as an extreme long-shot in their respective party races. At a 1% price, markets imply a roughly 1-in-100 probability of success—a level reserved for candidates who face structural barriers to nomination. For Warnock, these barriers include competition from established figures within the Democratic Party, his strong focus on Georgia politics, and the historic preference for sitting Presidents or nationally-visible alternatives during open primaries. For Kennedy, the obstacles are even steeper: the Republican Party's traditional ideological gatekeeping, his past party affiliation oscillations, and organized skepticism from GOP establishment figures concerning his vaccine skepticism and public health positions. The identical pricing suggests traders view both paths as equally implausible—a situation warranting careful monitoring. Interestingly, these outcomes could diverge sharply despite their current pricing symmetry. A Democratic primary in 2028 is likely to remain controlled by center-left party actors, making a Georgia-focused Senator a marginal figure unless he gains unexpected national momentum. By contrast, a Republican primary could be more vulnerable to a non-traditional candidacy if frontrunners falter or if anti-establishment sentiment within the GOP base surges. The two markets would likely remain uncorrelated—a Warnock surge in Democratic horse-race polling would not mechanically influence Kennedy's Republican odds, and vice versa. However, broader dynamics could affect both: deteriorating economic sentiment might boost anti-establishment candidates across both parties, while normalizing political conditions would likely reinforce the dominance of conventional nominees. Observers should track several leading indicators. For Warnock, monitor his reelection trajectory in Georgia (a 2024 race), his profile elevation in national Democratic circles, and any major legislative achievements that shift the national conversation. For Kennedy, watch his media presence, any significant splits within the GOP over public health policy, and whether Republicanism's anti-establishment wing gains ground in early nomination contests. The 1% pricing on both suggests current market sentiment is deeply skeptical of both paths, but nomination races remain notoriously fluid—either candidate's probability could shift meaningfully if early primaries or major news events force a reassessment.